EUVIMEDEUVIMED entdecken
Crossref

Design and Synthesis of O ‐Dialkylaminoalkyl Substituted Urolithin Derivatives: DNA Topoisomerase IIα Inhibition With Promising Antiproliferative Activity

Xintong Li, Xiaochun Zhang, Chan Yin, Chunhua Lu iD, Yuemao Shen

Archiv der Pharmazie · 2025

DOI: 10.1002/ardp.70009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Xintong Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Department of Natural Products Chemistry,…. Hauptthemen laut MEDLINE: Topoisomerase II Inhibitors, DNA Topoisomerases, Type II, Antineoplastic Agents, Drug Design. Die Arbeit nennt 51 Literaturangaben. Gefördert von: This study was financially supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT_17R68), Germplasm innovation and ef….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Based on the pharmacophore structural characteristics of topoisomerase II (TopoII) inhibitors: (i) planar polyaromatic skeleton; (ii) the cation core; (iii) a groove‐binding side chain moiety, 16 urolithin derivatives with O ‐dialkylaminoalkyl substitutions were designed and synthesized. Most of the synthesized compounds showed improved TopoIIα inhibitory and antiproliferative activities. 20 with the best TopoIIα inhibitory activity also exhibited excellent antiproliferative activity with IC 50 values of 0.91 ± 0.01, 1.93 ± 0.04, and 2.84 ± 0.34 μM against the MDA‐MB‐231, HeLa, and A549 cell lines, being about 12.55, 3.95, and 2.17 times more active than VP‐16 (IC 50 11.42 ± 0.82, 7.63 ± 0.46, and 6.15 ± 0.43 μM, respectively). Meanwhile, 20 exhibited weak toxicity to normal cells. In addition, 20 exerted anti‐migration and anti‐invasion activity against MDA‐MB‐231 cells. Our results supported that 20 might act as TopoIIα inhibitor with the potential to become a new type of antitumor drug lead.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Topoisomerase II InhibitorsDNA Topoisomerases, Type IIAntineoplastic AgentsDrug DesignCoumarinsHumansCell ProliferationStructure-Activity RelationshipDrug Screening Assays, AntitumorCell Line, TumorMolecular StructureDose-Response Relationship, Drug

Stichwörter der Autor:innen

antiproliferative activitiesstructure‐activity relationshiptopoisomerase II inhibitorurolithin

Substanzen

Topoisomerase II InhibitorsDNA Topoisomerases, Type IIAntineoplastic AgentsCoumarins

Autor:innen und Institutionen

  • State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Department of Natural Products Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, China.

ORCID-Profile: Chunhua Lu

Förderung

  • This study was financially supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT_17R68), Germplasm innovation and ef…

Zitieren

APA

Li, X., Zhang, X., Yin, C., Lu, C., & Shen, Y. (2025). Design and Synthesis of O ‐Dialkylaminoalkyl Substituted Urolithin Derivatives: DNA Topoisomerase IIα Inhibition With Promising Antiproliferative Activity. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70009

Vancouver

Li X, Zhang X, Yin C, Lu C, Shen Y. Design and Synthesis of O ‐Dialkylaminoalkyl Substituted Urolithin Derivatives: DNA Topoisomerase IIα Inhibition With Promising Antiproliferative Activity. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70009

BibTeX
@article{Li2025,
  author = {Li, Xintong and Zhang, Xiaochun and Yin, Chan and Lu, Chunhua and Shen, Yuemao},
  title = {Design and Synthesis of O ‐Dialkylaminoalkyl Substituted Urolithin Derivatives: DNA Topoisomerase IIα Inhibition With Promising Antiproliferative Activity},
  journal = {Archiv der Pharmazie},
  year = {2025},
  doi = {10.1002/ardp.70009}
}
Kostenlos starten →